All In MedTech

Device Trial Radar · NCT04129034

Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain

Last checked: Nov 20, 2026Latest source record: Dec 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

30

Actual

Start

Sep 24, 2019

Primary completion

Oct 26, 2022

Study completion Mar 26, 2023

Sponsor

Lead sponsor
FUSMobile Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 16, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 55 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Single arm pilot study to evaluate the safety and initial feasibility of the Neurolyser XR, a high intensity focused ultrasound device, for non-invasive treatment of axial chronic low back pain

Conditions

  • Facet Syndrome of Lumbar Spine

Interventions

  • Neurolyser XRDevice

    Non-Invasive Thermal Ablation of the Medial Branch Nerves

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. NRSTime frame: Time Frame: Base line, 2 days 1, 2 & 4 weeks, 3 & 6 months after procedure
  2. Procedure and Device Safety at six months as measured by measured by the incidence and severity of treatment related adverse eventsTime frame: Time Frame: 6 months after procedure

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Kinetix Medicine

    Vancouver, British Columbia, Canada

  • Precision Sport & Spine

    Oakville, Ontario, Canada

  • Silver Medical Group

    Toronto, Ontario, Canada

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.